Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.91 is 79% above its 5-year average of -9.27, near the high end of its 5-year range (-25.50–-1.91).
24.36% above its 12-month average of -2.52.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.38.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 34 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.91
EARNINGS PER SHARE (EPS) AVG TTM
-2.52
EARNINGS PER SHARE (EPS) AVG 3Y
-4.99
EARNINGS PER SHARE (EPS) AVG 5Y
-9.27
EARNINGS PER SHARE (EPS) AVG 10Y
-16.22
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+24.36%
CURRENT VS 3Y AVG
+61.76%
CURRENT VS 5Y AVG
+79.40%
CURRENT VS 10Y AVG
+88.23%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Solid Biosciences Inc.
Market Cap
$684.72M
Earnings Per Share (EPS)
-1.91
TTM Avg
-2.52
3Y Avg
-4.99
5Y Avg
-9.27
Market Cap
$687.17M
Earnings Per Share (EPS)
-2.46
TTM Avg
-3.34
3Y Avg
-3.80
5Y Avg
-4.24
Market Cap
$693.98M
Earnings Per Share (EPS)
-1.09
TTM Avg
-0.95
3Y Avg
-1.13
5Y Avg
-1.78
Market Cap
$696.67M
Earnings Per Share (EPS)
-2.76
TTM Avg
-3.16
3Y Avg
-2.11
5Y Avg
-1.54
Market Cap
$671.23M
Earnings Per Share (EPS)
-2.72
TTM Avg
-2.70
3Y Avg
-2.77
5Y Avg
-2.61
Market Cap
$697.91M
Earnings Per Share (EPS)
-2.13
TTM Avg
-2.04
3Y Avg
-2.21
5Y Avg
-1.87
Market Cap
$667.69M
Earnings Per Share (EPS)
-1.16
TTM Avg
-1.18
3Y Avg
-1.68
5Y Avg
-2.29
Market Cap
$667.57M
Earnings Per Share (EPS)
-5.51
TTM Avg
-4.06
3Y Avg
-4.55
5Y Avg
-6.70
Market Cap
$665.83M
Earnings Per Share (EPS)
0.04
TTM Avg
0.31
3Y Avg
0.21
5Y Avg
0.05
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | $684.72M | -1.91 | -2.52 | -4.99 | -9.27 |
| Verastem, Inc. (VSTM)vs › | $687.17M | -2.46 | -3.34 | -3.80 | -4.24 |
| Wave Life Sciences Ltd. (WVE)vs › | $693.98M | -1.09 | -0.95 | -1.13 | -1.78 |
| Anteris Technologies Global Corp. (AVR)vs › | $696.67M | -2.76 | -3.16 | -2.11 | -1.54 |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $671.23M | -2.72 | -2.70 | -2.77 | -2.61 |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $697.91M | -2.13 | -2.04 | -2.21 | -1.87 |
| Annexon, Inc. (ANNX)vs › | $667.69M | -1.16 | -1.18 | -1.68 | -2.29 |
| Helus Pharma Inc. (HELP)vs › | $667.57M | -5.51 | -4.06 | -4.55 | -6.70 |
| MiMedx Group, Inc. (MDXG)vs › | $665.83M | 0.04 | 0.31 | 0.21 | 0.05 |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $713.22M | 1.24 | 2.06 | 1.25 | 1.30 |
Trailing EPS (TTM)
$-1.91
Forward EPS (Est.)
$-1.75
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.99 |
| 2024-12-31 | -3.06 |
| 2023-12-31 | -4.83 |
| 2022-12-31 | -10.10 |
| 2021-12-31 | -10.14 |
| 2020-12-31 | -25.50 |
| 2019-12-31 | -43.05 |
| 2018-12-31 | -33.73 |
| 2017-12-31 | -24.26 |
| 2016-12-31 | -16.80 |
| 2015-12-31 | -4.97 |
